Literature DB >> 3263937

Segregation of lymphocyte low-molecular-weight DNA and antinuclear-antibodies in a family with systemic lupus erythematosus in first cousins.

H Levcovitz1, M A Fletcher, P Phillips, H A Chertok, R Altman, P J Benke.   

Abstract

All patients with systemic lupus erythematosus (SLE) demonstrated two classes of newly synthesized DNA in sucrose density gradients of PHA (phytohemagglutinin)-stimulated lymphocytes: a large-molecular-weight fraction that comigrates with control DNA and an excess low-molecular-weight DNA (LMW-DNA) fraction not found in control lymphocytes. Excess LMW-DNA was independent of disease activity or drug therapy. LMW-DNA and serologic abnormalities were studied in a four-generation family in which two first cousins had SLE. Excess LMW-DNA was found in the cousins with SLE, sibling parents of the SLE patients, a common grandparent, four of nine siblings of one patient, and five of seven at risk children. Both males and females had excess LMW-DNA. Male-male transmission was observed. The expression of excess LMW-DNA in stimulated lymphocytes is inherited as an autosomal dominant genetic trait in this family. All unaffected adult family members with the marker had positive antinuclear antibodies (ANAs) except the grandmother. However, none of the five children with excess LMW-DNA showed positive ANAs. Excess LMW-DNA precedes the appearance of ANAs when found in children of adults with excess LMW-DNA, and may be a predisposing factor in the development of the immunologic responses of systemic lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263937     DOI: 10.1007/bf01790093

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  31 in total

1.  Evidence that autoimmunity in man is a Mendelian dominant trait.

Authors:  W B Bias; J D Reveille; T H Beaty; D A Meyers; F C Arnett
Journal:  Am J Hum Genet       Date:  1986-11       Impact factor: 11.025

2.  Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset.

Authors:  P B Nakajima; S K Datta; R S Schwartz; B T Huber
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  The antigenic potential and specificity of nucleic acids, nucleoproteins, and their modified derivatives.

Authors:  B D Stollar
Journal:  Arthritis Rheum       Date:  1981-08

Review 4.  Systemic lupus erythematosus: current state of the genetic hypothesis.

Authors:  F C Arnett; J D Reveille; R W Wilson; T T Provost; W B Bias
Journal:  Semin Arthritis Rheum       Date:  1984-08       Impact factor: 5.532

5.  Systemic lupus erythematosus following total body irradiation for malignant lymphoma.

Authors:  F Spinozzi; E Capodicasa; R Gerli; A Bertotto; P Rambotti; F Grignani
Journal:  Allergol Immunopathol (Madr)       Date:  1986 May-Jun       Impact factor: 1.667

6.  Responsiveness of autoimmune and normal mice to nucleic acid antigens.

Authors:  M P Madaio; S Hodder; R S Schwartz; B D Stollar
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

7.  Familial systemic lupus erythematosus: immunogenetic studies in eight families.

Authors:  J D Reveille; W B Bias; J A Winkelstein; T T Provost; C A Dorsch; F C Arnett
Journal:  Medicine (Baltimore)       Date:  1983-01       Impact factor: 1.889

8.  Accumulation of guanine-cytosine-enriched low M.W. DNA fragments in lymphocytes of patients with systemic lupus erythematosus.

Authors:  H Sano; M Imokawa; A D Steinberg; C Morimoto
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

9.  Immune response to nucleic acid antigens and native DNA by human peripheral blood lymphocytes in vitro.

Authors:  D Bastian; H Borel; T Sasaki; A D Steinberg; Y Borel
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures.

Authors:  T Paavonen; L C Andersson; H Adlercreutz
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.